ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

ORI Final Findings Of Scientific Misconduct

September 16, 1994

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

In Brief: AC Committee Picks Seffrin for Executive VP; Charles Wilson Names to NCAB; 5 Leave Board

May 15, 1992

Clinical Trials Approved By NCI

November 28, 2003

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006